New Results
Reprogramming of serine metabolism is an actionable vulnerability in FLT3-ITD driven acute myeloid leukaemia
View ORCID ProfileStefan Bjelosevic, Emily Gruber, Andrea Newbold, Lev M. Kats, View ORCID ProfileCarolyn Shembrey, Thomas C. Abrehart, Izabela Todorovski, Giovanna Pomilio, View ORCID ProfileAndrew H. Wei, View ORCID ProfileGareth P. Gregory, View ORCID ProfileStephin J. Vervoort, View ORCID ProfileKristin K. Brown, View ORCID ProfileRicky W. Johnstone
doi: https://doi.org/10.1101/2020.05.26.116392
Stefan Bjelosevic
1Translational Haematology Program, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia
2The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
Emily Gruber
1Translational Haematology Program, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia
2The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
Andrea Newbold
1Translational Haematology Program, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia
Lev M. Kats
1Translational Haematology Program, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia
2The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
Carolyn Shembrey
3Department of Clinical Pathology, The University of Melbourne, Melbourne, Australia
4Centre for Cancer Research, The University of Melbourne, Melbourne, Australia
Thomas C. Abrehart
1Translational Haematology Program, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia
Izabela Todorovski
1Translational Haematology Program, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia
2The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
Giovanna Pomilio
5Australian Centre for Blood Diseases, Monash University, Melbourne, Australia
6Department of Clinical Haematology, The Alfred Hospital, Melbourne, Australia
Andrew H. Wei
5Australian Centre for Blood Diseases, Monash University, Melbourne, Australia
6Department of Clinical Haematology, The Alfred Hospital, Melbourne, Australia
7Department of Pathology, The Alfred Hospital, Melbourne, Australia
Gareth P. Gregory
1Translational Haematology Program, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia
8School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia
Stephin J. Vervoort
1Translational Haematology Program, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia
2The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
Kristin K. Brown
2The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
9Cancer Metabolism Program and Cancer Therapeutics Program, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia
10Department of Biochemistry and Molecular Biology, The University of Melbourne, Melbourne, Australia
Ricky W. Johnstone
1Translational Haematology Program, Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia
2The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia
Posted May 27, 2020.
Reprogramming of serine metabolism is an actionable vulnerability in FLT3-ITD driven acute myeloid leukaemia
Stefan Bjelosevic, Emily Gruber, Andrea Newbold, Lev M. Kats, Carolyn Shembrey, Thomas C. Abrehart, Izabela Todorovski, Giovanna Pomilio, Andrew H. Wei, Gareth P. Gregory, Stephin J. Vervoort, Kristin K. Brown, Ricky W. Johnstone
bioRxiv 2020.05.26.116392; doi: https://doi.org/10.1101/2020.05.26.116392
Reprogramming of serine metabolism is an actionable vulnerability in FLT3-ITD driven acute myeloid leukaemia
Stefan Bjelosevic, Emily Gruber, Andrea Newbold, Lev M. Kats, Carolyn Shembrey, Thomas C. Abrehart, Izabela Todorovski, Giovanna Pomilio, Andrew H. Wei, Gareth P. Gregory, Stephin J. Vervoort, Kristin K. Brown, Ricky W. Johnstone
bioRxiv 2020.05.26.116392; doi: https://doi.org/10.1101/2020.05.26.116392
Subject Area
Subject Areas
- Biochemistry (11730)
- Bioengineering (8743)
- Bioinformatics (29179)
- Biophysics (14964)
- Cancer Biology (12080)
- Cell Biology (17399)
- Clinical Trials (138)
- Developmental Biology (9417)
- Ecology (14174)
- Epidemiology (2067)
- Evolutionary Biology (18294)
- Genetics (12233)
- Genomics (16791)
- Immunology (11858)
- Microbiology (28051)
- Molecular Biology (11575)
- Neuroscience (60919)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4955)
- Plant Biology (10422)
- Synthetic Biology (2881)
- Systems Biology (7338)
- Zoology (1650)